Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017 2018 2019 2020

Details for Mechanism ID: 18219
Country/Region: Ukraine
Year: 2017
Main Partner: Ministry of Health
Main Partner Program: NA
Organizational Type: Implementing Agency
Funding Agency: HHS/CDC
Total Funding: $1,800,000 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Treatment: Adult Treatment (HTXS) $1,800,000
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
TX_CURR Aggregated Age/Sex: <15 Female 2018 1,174
TX_CURR Aggregated Age/Sex: <15 Male 2018 1,043
TX_CURR Aggregated Age/Sex: 15+ Female 2018 46,366
TX_CURR Aggregated Age/Sex: 15+ Male 2018 52,277
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 100,860
TX_CURR Sum of Aggregated Age/Sex <15 2018 2,217
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 98,643
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 100,860
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 1
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 19,252
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 21,705
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 40,956
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 40,958
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 81,378
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 73,244
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 1,003
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 52
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 892
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 47
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 31,818
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 1,672
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 35,879
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 1,889
TX_PVLS Numerator: Indication: Routine 2018 69,583
TX_PVLS Numerator: Indication: Targeted 2018 3,658
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 512
TX_PVLS Undocumented Test Indication 2018 3
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 1,116
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 59
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 991
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 52
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 35,343
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 1,848
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 39,860
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 2,103
TX_PVLS_den Denominator: Indication: Routine 2018 77,316
TX_PVLS_den Denominator: Indication: Targeted 2018 4,060
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 512
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 3
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 1
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 7,227
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 8,162
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 15,393
TX_RET Numerator by Status: Pregnant 2018 515
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 17,102
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 3
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 1
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 8,034
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 9,062
TX_RET_den Denominator by Status: Pregnant 2018 515
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 75,290
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 5,724
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 1,716
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 4,006
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Female 2018 35,386
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Male 2018 39,904
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 6,021
TX_TB_den Denominator: By Screen Result: Negative 2018 69,269
TX_TB_den Denominator: By Screen Result: Positive 2018 6,021
TX_TB_den Denominator: By Specimen Sent: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 6,021
Cross Cutting Budget Categories and Known Amounts Total: $30,000
Human Resources for Health $30,000